ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Nexus Pharmaceuticals announces approval of Emerphed injection pharmaceutical-business-review
April 26, 2020Nexus Pharmaceuticals announced that has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, the first and only premixed ephedrine in a ready-to-use 50 mg/10 mL vial.
Pharma Sources Insight July 2025
